
Clinigen aims to deliver right medicine to the patient through areas of global medicine supply. (Image source: liz west/Flickr)
Clinigen Group plc, the global pharmaceutical and services company, has partnered with Eisai Europe Ltd to obtain the marketing authorisation and subsequently launch Halaven (eribulin), Fycompa (perampanel) and Lenvima (lenvatinib) into 10 African countries